And, despite increasing their total shorted from 3% to nearly 4% this month - they haven't done much to the share price, it has bounced between 1.40 and 1.20.
It's obviously costing them much more risk to try and cap the price now - they used to be able to cover most shares they shorted and still drive the price down.
I'm guessing true selling is drying up, and maybe there's some more buying pressure competing.
I predict this will be the trend as PNV continues to prove itself. Eventually the risk will be too high to continue holding the price down - and as soon as the risk/reward shifts they'll leave it be.
IMO.
The Clinicians Speak, page-655
-
- There are more pages in this discussion • 379 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.61 |
Change
0.090(3.57%) |
Mkt cap ! $1.801B | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.66 | $2.58 | $3.183M | 1.217M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19229 | $2.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.62 | 3084 | 2 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |